However, there was a trend in the reduction of KIM-1 concentration for both doses of the extract (75.54 ± 33.98 ng/mg vs. 134.54 ± 93.23 ng/mL, p = 0.310 for MetS+100 vs. MetS-Control and 73.92 ± 22.85 ng/mL vs. 134.54 ± 93.23 ng/mL, p = 0.421 for MetS+200 vs. MetS-Control). This evidence concerns the gene HAVCR1 and metabolic syndrome.